Abstract
Hepatocellular carcinoma (HCC) is one of the most frequent-occurring malignant tumours worldwide, but molecular changes of tumour DNA, with the exception of viral integrations and p53 mutations, are poorly understood. In order to search for common macro-imbalances of genomic tumour DNA, 21 HCCs and 3 HCC-cell lines were characterized by comparative genomic hybridization (CGH), subsequent database analyses and in selected cases by fluorescence in situ hybridization (FISH). Chromosomal subregions of 1q, 8q, 17q and 20q showed frequent gains of genomic material, while losses were most prevalent in subregions of 4q, 6q, 13q and 16q. Deleted regions encompass tumour suppressor genes, like RB-1 and the cadherin gene cluster, some of them previously identified as potential target genes in HCC development. Several potential growth- or transformation-promoting genes located in chromosomal subregions showed frequent gains of genomic material. The present study provides a basis for further genomic and expression analyses in HCCs and in addition suggests chromosome 4q to carry a so far unidentified tumour suppressor gene relevant for HCC development. © 2001 Cancer Research Campaign www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Albertoni, M, Daub, DM, Arden, KC, Viars, CS, Powell, C & Van Meir, EG (1998). Genetic instability leads to loss of both p53 alleles in a human glioblastoma. Oncogene, 16, 321–326.
Benbrook, D, Lernhardt, E & Pfahl, M (1988). A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature, 333, 669–672.
Berx, G, Cleton-Jansen, AM, Nollet, F, de Leeuw, WJ, Van de Vijver, M, Cornelisse, C & Van Roy, F (1995). E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J, 14, 6107–6115.
Bosch, FX (1997). Global epidemiology of hepatocellular carcinoma. Okuda K, Tabor E (eds) Liver Cancer, 13–28, Churchill Livingstone: New York, Edinburgh, London, Madrid, Melbourne, San Francisco, Tokyo
Bressac, J, Kew, M, Wands, J & Ozturk, M (1991). Selective G to T mutations of the p53 gene in hepatocellular carcinoma from southern Africa. Nature, 350, 429–431.
Buetow, KH, Murray, JC, Israel, JL, London, WT, Smith, M, Kew, M, Blanquet, V, Brechot, C, Redeker, A & Govindarajah, S (1989). Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA, 86, 8852–8856.
Chou, YH, Chung, KC, Jeng, LB, Chen, TC & Liaw, YF (1998). Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan. Cancer Lett, 123, 1–6.
de la Coste, A, Romagnolo, B, Billuart, P, Renard, CA, Buendia, MA, Soubrane, O, Fabre, M, Chelly, J, Beldjord, C, Kahn, A & Perret, C (1998). Somatic mutation of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA, 95, 8847–8851.
Deloukas, P, Schuler, GD, Gyapay, G, Beasley, EM, Soderlund, C, Rodriguez-Tome, P, Hui, L, Matise, TC, McKusick, KB, Beckmann, JS, Bentolila, S, Bihoreau, MT, Birren, BB, Browne, J, Butler, A, Castle, AB, Chiannilkulchai, N, Clee, C, Day, PJR, Dehejian, A, Dibling, T, Drouot, N, Duprat, S, Fizames, C, Fox, S, Gelling, S, Green, L, Harrison, P, Hocking, R, Holloway, E, Hunt, S, Keil, S, Lijnzaad, P, Louis-Dit-Sully, C, MaJMendis, A, Miller, J, Morissette, J, Muselet, D, Nusbaum, HC, Peck, A, Rozen, S, Simon, D, Slonim, DK, Staples, R, Stein, DL, Stewart, EA, Suchard, MA, Thangarajah, T, Vega-Czarny, N, Webber, C, Wu, X, Hudson, J, Auffray, C, Nomura, N, Sikela, MJ, Polymeropoulos, MH, James, MR, Lander, ES, Hudson, TJ, Myers, RM, Cox, DR, Weissenbach, J, Boguski, MS & Bentley, DR (1998). A physical map of 30,000 human genes. Science, 282, 744–746.
Derynck, R, Goeddel, DV, Ullrich, A, Gutterman, JU, Williams, RD, Bringman, TS & Berger, WH (1987). Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res, 47, 707–712.
de The, H, Marchio, A, Tiollais, P & Dejean, A (1987). A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature, 330, 667–670.
du Manoir, S, Schröck, E, Bentz, M, Speicher, MR, Joos, S, Ried, T, Lichter, P & Cremer, T (1995). Quantitative analysis of comparative genomic hybridization. Cytometry, 19, 27–41.
Fourel, G, Trepo, C, Bougueleret, L, Henglein, B, Ponzetto, A, Tiollais, P & Buendia, MA (1990). Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors. Nature, 347, 294–298.
Frixen, UH, Behrens, J, Sachs, M, Eberle, G, Voss, B, Warda, A, Lochner, D & Birchmeier, W (1991). E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol, 113, 173–185.
Fujimoto, Y, Hampton, LL, Wirth, PJ, Wang, NJ, Xie, JP & Thorgeirsson, SS (1994). Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res, 54, 281–285.
Geissler, M, Gesien, A & Wands, JR (1997). Molecular mechanisms of hepato-carcinogenesis. Okuda K, Tabor E (eds) Liver Cancer, 59–88, Churchill Livingstone: New York, Edinburgh, London, Madrid, Melbourne, San Francisco, Tokyo
Graff, JR, Herman, JG, Lapidus, RG, Chopra, H, Xu, R, Jarrard, DF, Isaacs, WB, Pitha, PM, Davidson, NE & Baylin, SB (1995). E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res, 55, 5195–5199.
Gschwend, M, Levran, O, Kruglyak, L, Ranade, K, Verlander, PC, Shen, S, Faure, S, Weissenbach, J, Altay, C, Lander, ES, Auerbach, AD & Botstein, D (1996). A locus for Fanconi anemia on 16q determined by homozygosity mapping. Am J Hum Genet, 59, 377–384.
Guilford, P, Hopkins, J, Harraway, J, McLeod, M, McLeod, N, Harawira, P, Taita, H, Scoular, R, Miller, A & Reeve, AE (1998). E-cadherin germline mutations in familial gastric cancer. Nature, 392, 402–405.
Hata, A, Shi, Y & Massague, J (1998). TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads. Mol Med Today, 4, 257–262.
Hopman, AHN, Poddighe, P, Moesker, O & Ramaekers, FCS (1992). Interphase cytogenetics: an approach to the detection of genetic aberrations in tumors. Herrington CS, Mc Gee JO'D (eds) Diagnostic Molecular Pathology A Practical Approach, 141–163.
Hsu, IC, Metcalf, RA, Sun, T, Welsh, JA, Wang, NJ & Harris, CC (1991). Mutation hotspot in the p53 gene in human hepatocellular carcinomas. Nature, 350, 427–428.
Huber, BE & Thorgeirsson, SS (1987). Analysis of c-myc expression in a human hepatoma cell line. Cancer Res, 47, 3414–3420.
Ishak, KG, Anthony, PP & Sobin, LH (1994). Histological Typing of Tumors of the Liver, 125 Springer: Berlin
Konishi, M, Kikuchi-Yanoshita, R, Tanaka, K, Sato, C, Tsuruta, K, Maeda, Y, Koike, M, Tanaka, S, Nakamura, Y, Hattori, N & Miyaki, M (1993). Genetic changes and histopathological grades in human hepatocellular carcinomas. Cancer Res, 84, 893–899.
Koskinen, PJ & Alitalo, K (1993). Role of myc amplification and overexpression in cell growth, differentiation and death. Semin Cancer Biol, 4, 3–12.
Lichter, P, Bentz, M, du Manoir, S & Joos, S (1994). Comparative genomic hybridization. Verma R, Babu A (eds) Human Chromosomes, 191–210, Mc Graw-Hill: New York
Marchio, A, Meddeb, M, Pineau, P, Danglot, G, Tiollais, P, Bernheim, A & Dejean, A (1997). Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridisation. Genes Chromosomes Cancer, 18, 59–65.
McMahon, G, Davis, EF, Huber, LJ, Kim, Y & Wogan, GN (1990). Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors. Proc Natl Acad Sci USA, 87, 1104–1108.
Murakami, Y, Hayashi, Y, Hirohashi, S & Sekiya, T (1991). Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinoma. Cancer Res, 51, 5520–5525.
Nagai, H, Pineau, P, Tiollais, P, Buendia, MA & Dejean, A (1997). Comprehensive allelotyping of hepatocellular carcinoma. Oncogene, 14, 2927–2933.
Nishida, N, Fukuda, Y, Kokuryu, H, Sedamoto, T, Isowa, G, Honda, K, Yamaoka, Y, Ikenaga, M, Imura, H & Ishizaki, K (1992). Accumulation of allelic loss on arms of chromosome 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer, 51, 862–868.
Nong, Z, Siegel, K, Odenthal, M, Becker, R, Oesch, F, Dienes, HP, Schirmacher, P & Steinberg, P (1997). The role of insulin-like growth factor II in the malignant transformation of liver oval cells. Hepatology, 25, 900–905.
Pasquinelli, C, Garreau, F, Bougueleret, L, Cariani, E, Grzeschik, KH, Thiers, V, Croissant, O, Hadchouel, M, Tiollais, P & Brechot, C (1988). Rearrangement of a common cellular DNA domain on chromosome 4 in human liver tumors. J Virol, 62, 629–632.
Sambrook, J, Fritsch, EF & Maniatis, T (1989). Molecular cloning: A laboratory manual, Laboratory Press: Cold Spring Harbor
Schirmacher, P, Held, WA, Yang, D, Chisari, FV, Rustum, Y & Rogler, CE (1992). Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res, 52, 2549–2556.
Schirmacher, P & Dienes, HP (1999). Hepatocellular carcinoma. Kurzrock R, Talpaz M (eds) Molecular Biology in Cancer Medicine, 355–366, Martin Dunitz: London, Malden, Winnipeg, Sao Paulo (eds)
Schutte, M, da Costa, LT, Hahn, SA, Moskaluk, C, Hoque, ATMS, Rozenblum, E, Weinstein, CL, Bittner, M, Meltzer, PS, Trent, JM, Yeo, CJ, Hruban, RH & Kern, SE (1995). Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci USA, 92, 5950–5954.
Sinha, S, Webber, C, Marshall, CJ, Knowles, MA, Proctor, A, Barrass, NC & Neal, GE (1988). Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis. Proc Natl Acad Sci USA, 85, 3673–3677.
Shimoyama, Y & Hirohashi, S (1991). Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett, 57, 131–135.
Sun, Y, Lix, X, Eaton, EN, Lane, WS, Lodish, HF & Weinberg, RA (1999). Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol Cell, 4, 499–509.
Teng, DHF, Bogden, R, Mitchell, J, Baumgard, MIIR, Berry, S, David, T, Ha, PC, Kehrer, R, Jammulapati, S, Chen, Q, Offit, K, Skolnick, MH, Tavtigian, SV, Jhanwar, S, Swedlund, B, Wong, AKC & Kamb, A (1996). Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nature Genet, 13, 241–244.
Tsuda, H, Zhang, W, Shimosato, Y, Yokota, J, Terada, M, Sugimura, T, Miyamura, T & Hirohashi, S (1990). Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA, 87, 6791–6794.
Tsuda, H, Oda, T, Sakamoto, M & Hirohashi, S (1992). Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin. Cancer Res, 52, 1504–1509.
Vleminckx, K, Vakaet, L, Mareel, M, Fiers, W & Roy, FV (1991). Genetic manipulation of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role. Cell, 66, 107–119.
Vogel, W & Speit, G (1985). Zytogenetik. Wolf U, Winkler U (eds) Humangenetik, 10–16, Springer-Verlag: Berlin, Heidelberg, New York, Tokyo
Walker, GJ, Hayward, NK, Falvey, S & Cooksely, WG (1991). Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res, 51, 4367–4370.
Weinstein, S, Scottalini, AG, Loo, SYT, Caldwell, PC & Bhagavan, NV (1995). Ataxia teleangiectasia with hepatocellular carcinoma in a 15 year old girl and studies of her kindred. Arch Pathol Lab Med, 109, 1000–1004 (1985).
Wong, N, Lai, P, Lee, SW, Fan, S, Pang, E, Liew, CT, Sheng, Z, Lau, JW & Janson, PJ (1999). Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analyses: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol, 154, 37–43.
Wooster, R, Neuhausen, SL, Mangion, J, Quirk, Y, Ford, D, Collins, N, Nguyen, K, Seal Tran, T, Averill, D, Fields, P, Marshall, G, Narod, S, Lenoir, GM, Lynch, H, Feunteun, J, Devilee, P, Cornelisse, CJ, Menko, FH, Daly, PA, Ormiston, W, McManus, R, Pye, C, Lewis, CM, Cannon-Albright, LA, Peto, J, Ponder, BAJ, Skolnick, MH, Easton, DF, Goldgar, DE & Stratton, MR (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science, 265, 2088–2090.
Wooster, R, Bignell, G, Lancaster, J, Swift, S, Seal, S, Mangion, J, Collins, N, Gregory, S, Gumbs, C, Micklem, G, Barfoot, R, Hamoudi, R, Patel, S, Rice, C, Biggs, P, Hashim, Y, Smith, A, Connor, F, Arason, A, Gudmundsson, J, Ficenec, D, Keisell, D, Ford, D, Tonin, P, Biship, DT, Spurr, NK, Ponder, BAJ, Eeles, R, Peto, J, Devilee, P, Cornelisse, C, Lynch, H, Narod, S, Lenoir, G, Egilsson, V, Barkadottir, RB, Easton, DF, Bentley, DR, Futreal, PA, Ashworth, A & Stratton, MR (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789–792.
Yamada, T, De Souza, AT, Finkelstein, S & Jirtle, RL (1997). Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA, 94, 10351–10355.
Yeh, SH, Chen, PJ, Lai, MY & Chen, DS (1996). Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated α-fetoprotein. Gastroenterology, 110, 184–192.
Zhang, W, Hirohashi, S, Tsuda, H, Shimosato, Y, Yokota, J, Terada, M & Sugimura, T (1990). Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res, 81, 108–111.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Niketeghad, F., Decker, H., Caselmann, W. et al. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer 85, 697–704 (2001). https://doi.org/10.1054/bjoc.2001.1963
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2001.1963
Keywords
This article is cited by
-
Recurrent amplification of RTEL1 and ABCA13 and its synergistic effect associated with clinicopathological data of gastric adenocarcinoma
Molecular Cytogenetics (2016)
-
Analysis of Genetic Damage and Gene Polymorphism in Hepatocellular Carcinoma (HCC) Patients in a South Indian Population
Digestive Diseases and Sciences (2013)
-
Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma
Oncogene (2012)
-
Generation of a mouse model for studying the role of upregulated RTEL1 activity in tumorigenesis
Transgenic Research (2012)
-
Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma
Acta Pharmacologica Sinica (2010)
